MYC protein expression and genetic alterations have prognostic impact in diffuse large B-cell lymphoma treated with immunochemotherapy
MYC alterations influence the survival of patients with diffuse large B-cell lymphoma. Most studies have focused on MYC translocations but there is little information regarding the impact of numerical alterations and protein expression. We analyzed the genetic alterations and protein expression of M...
| Autores: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2013 |
| País: | España |
| Recursos: | Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya) |
| Repositorio: | Recercat. Dipósit de la Recerca de Catalunya |
| OAI Identifier: | oai:recercat.cat:2445/68680 |
| Acesso em linha: | https://hdl.handle.net/2445/68680 |
| Access Level: | acceso abierto |
| Palavra-chave: | Limfomes Immunoteràpia Oncogens Pronòstic mèdic Lymphomas Immunotheraphy Oncogenes Prognosis |
| id |
ES_f680d6a02f697d57915f962a25ddac0f |
|---|---|
| oai_identifier_str |
oai:recercat.cat:2445/68680 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
MYC protein expression and genetic alterations have prognostic impact in diffuse large B-cell lymphoma treated with immunochemotherapyValera Barros, AlexandraLópez Guillermo, ArmandoCardesa García, AntonioCliment, FinaGonzález Barca, EvaMercadal, SantiagoEspinosa, IñigoNovelli, SilvanaBriones, JavierMate, José L.Salamero, OlgaSancho, Juan ManuelArenillas Rocha, LeonorSerrano, SergiErill, NadinaMartínez, DanielCastillo, PaolaRovira, JordinaMartínez, AntonioCampo Güerri, EliasColomo Saperas, LluísLimfomesImmunoteràpiaOncogensPronòstic mèdicLymphomasImmunotheraphyOncogenesPrognosisMYC alterations influence the survival of patients with diffuse large B-cell lymphoma. Most studies have focused on MYC translocations but there is little information regarding the impact of numerical alterations and protein expression. We analyzed the genetic alterations and protein expression of MYC, BCL2, BCL6, and MALT1 in 219 cases of diffuse large B-cell lymphoma. MYC rearrangement occurred as the sole abnormality (MYC single-hit) in 3% of cases, MYC and concurrent BCL2 and/or BCL6 rearrangements (MYC double/triple-hit) in 4%, MYC amplifications in 2% and MYC gains in 19%. MYC single-hit, MYC double/triple-hit and MYC amplifications, but not MYC gains or other gene rearrangements, were associated with unfavorable progression-free survival and overall survival. MYC protein expression, evaluated using computerized image analysis, captured the unfavorable prognosis of MYC translocations/amplifications and identified an additional subset of patients without gene alterations but with similar poor prognosis. Patients with tumors expressing both MYC/BCL2 had the worst prognosis, whereas those with double-negative tumors had the best outcome. High MYC expression was associated with shorter overall survival irrespectively of the International Prognostic Index and BCL2 expression. In conclusion, MYC protein expression identifies a subset of diffuse large B-cell lymphoma with very poor prognosis independently of gene alterations and other prognostic parameters.Ferrata Storti Foundation2016201620132016info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion9 p.application/pdfhttps://hdl.handle.net/2445/68680Articles publicats en revistes (Fonaments Clínics)reponame:Recercat. Dipósit de la Recerca de Catalunyainstname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)InglésReproducció del document publicat a: http://dx.doi.org/10.3324/haematol.2013.086173Haematologica, 2013, vol. 98, num. 10, p. 1554-1562http://dx.doi.org/10.3324/haematol.2013.086173(c) Ferrata Storti Foundation, 2013info:eu-repo/semantics/openAccessoai:recercat.cat:2445/686802026-05-29T05:05:01Z |
| dc.title.none.fl_str_mv |
MYC protein expression and genetic alterations have prognostic impact in diffuse large B-cell lymphoma treated with immunochemotherapy |
| title |
MYC protein expression and genetic alterations have prognostic impact in diffuse large B-cell lymphoma treated with immunochemotherapy |
| spellingShingle |
MYC protein expression and genetic alterations have prognostic impact in diffuse large B-cell lymphoma treated with immunochemotherapy Valera Barros, Alexandra Limfomes Immunoteràpia Oncogens Pronòstic mèdic Lymphomas Immunotheraphy Oncogenes Prognosis |
| title_short |
MYC protein expression and genetic alterations have prognostic impact in diffuse large B-cell lymphoma treated with immunochemotherapy |
| title_full |
MYC protein expression and genetic alterations have prognostic impact in diffuse large B-cell lymphoma treated with immunochemotherapy |
| title_fullStr |
MYC protein expression and genetic alterations have prognostic impact in diffuse large B-cell lymphoma treated with immunochemotherapy |
| title_full_unstemmed |
MYC protein expression and genetic alterations have prognostic impact in diffuse large B-cell lymphoma treated with immunochemotherapy |
| title_sort |
MYC protein expression and genetic alterations have prognostic impact in diffuse large B-cell lymphoma treated with immunochemotherapy |
| dc.creator.none.fl_str_mv |
Valera Barros, Alexandra López Guillermo, Armando Cardesa García, Antonio Climent, Fina González Barca, Eva Mercadal, Santiago Espinosa, Iñigo Novelli, Silvana Briones, Javier Mate, José L. Salamero, Olga Sancho, Juan Manuel Arenillas Rocha, Leonor Serrano, Sergi Erill, Nadina Martínez, Daniel Castillo, Paola Rovira, Jordina Martínez, Antonio Campo Güerri, Elias Colomo Saperas, Lluís |
| author |
Valera Barros, Alexandra |
| author_facet |
Valera Barros, Alexandra López Guillermo, Armando Cardesa García, Antonio Climent, Fina González Barca, Eva Mercadal, Santiago Espinosa, Iñigo Novelli, Silvana Briones, Javier Mate, José L. Salamero, Olga Sancho, Juan Manuel Arenillas Rocha, Leonor Serrano, Sergi Erill, Nadina Martínez, Daniel Castillo, Paola Rovira, Jordina Martínez, Antonio Campo Güerri, Elias Colomo Saperas, Lluís |
| author_role |
author |
| author2 |
López Guillermo, Armando Cardesa García, Antonio Climent, Fina González Barca, Eva Mercadal, Santiago Espinosa, Iñigo Novelli, Silvana Briones, Javier Mate, José L. Salamero, Olga Sancho, Juan Manuel Arenillas Rocha, Leonor Serrano, Sergi Erill, Nadina Martínez, Daniel Castillo, Paola Rovira, Jordina Martínez, Antonio Campo Güerri, Elias Colomo Saperas, Lluís |
| author2_role |
author author author author author author author author author author author author author author author author author author author author |
| dc.subject.none.fl_str_mv |
Limfomes Immunoteràpia Oncogens Pronòstic mèdic Lymphomas Immunotheraphy Oncogenes Prognosis |
| topic |
Limfomes Immunoteràpia Oncogens Pronòstic mèdic Lymphomas Immunotheraphy Oncogenes Prognosis |
| description |
MYC alterations influence the survival of patients with diffuse large B-cell lymphoma. Most studies have focused on MYC translocations but there is little information regarding the impact of numerical alterations and protein expression. We analyzed the genetic alterations and protein expression of MYC, BCL2, BCL6, and MALT1 in 219 cases of diffuse large B-cell lymphoma. MYC rearrangement occurred as the sole abnormality (MYC single-hit) in 3% of cases, MYC and concurrent BCL2 and/or BCL6 rearrangements (MYC double/triple-hit) in 4%, MYC amplifications in 2% and MYC gains in 19%. MYC single-hit, MYC double/triple-hit and MYC amplifications, but not MYC gains or other gene rearrangements, were associated with unfavorable progression-free survival and overall survival. MYC protein expression, evaluated using computerized image analysis, captured the unfavorable prognosis of MYC translocations/amplifications and identified an additional subset of patients without gene alterations but with similar poor prognosis. Patients with tumors expressing both MYC/BCL2 had the worst prognosis, whereas those with double-negative tumors had the best outcome. High MYC expression was associated with shorter overall survival irrespectively of the International Prognostic Index and BCL2 expression. In conclusion, MYC protein expression identifies a subset of diffuse large B-cell lymphoma with very poor prognosis independently of gene alterations and other prognostic parameters. |
| publishDate |
2013 |
| dc.date.none.fl_str_mv |
2013 2016 2016 2016 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
https://hdl.handle.net/2445/68680 |
| url |
https://hdl.handle.net/2445/68680 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
Reproducció del document publicat a: http://dx.doi.org/10.3324/haematol.2013.086173 Haematologica, 2013, vol. 98, num. 10, p. 1554-1562 http://dx.doi.org/10.3324/haematol.2013.086173 |
| dc.rights.none.fl_str_mv |
(c) Ferrata Storti Foundation, 2013 info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
(c) Ferrata Storti Foundation, 2013 |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
9 p. application/pdf |
| dc.publisher.none.fl_str_mv |
Ferrata Storti Foundation |
| publisher.none.fl_str_mv |
Ferrata Storti Foundation |
| dc.source.none.fl_str_mv |
Articles publicats en revistes (Fonaments Clínics) reponame:Recercat. Dipósit de la Recerca de Catalunya instname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya) |
| instname_str |
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya) |
| reponame_str |
Recercat. Dipósit de la Recerca de Catalunya |
| collection |
Recercat. Dipósit de la Recerca de Catalunya |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869424769164640256 |
| score |
15.811543 |